Standout Papers

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia... 2019 2026 2021 2023 438
  1. Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study (2019)
    Andrew H. Wei, Stephen A. Strickland et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 19 from Science/Nature 73 standout
Sub-graph 1 of 23

Citing Papers

Bridge RNAs direct programmable recombination of target and donor DNA
2024 StandoutNature
Acute myeloid leukaemia
2023 Standout
6 intermediate papers

Works of Tara L. Lin being referenced

CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial
2021
A Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML: Final Results
2020
and 6 more

Author Peers

Author Last Decade Papers Cites
Tara L. Lin 1454 554 1187 156 2.3k
Stephen A. Strickland 1740 486 1344 99 2.3k
Thomas Kindler 1641 605 1437 75 2.9k
Qaiser Bashir 1352 719 752 181 2.0k
Todd M. Cooper 1173 641 655 114 2.0k
Ellen K. Ritchie 2388 654 1338 171 3.5k
Stefan Früehauf 1601 1009 1080 119 3.1k
Martin Wermke 2176 1115 1188 146 3.6k
Lydia Campos 1692 897 1619 106 3.3k
Robert M. Rifkin 1564 1121 1397 143 2.4k
Agnieszka Wierzbowska 1405 468 1092 102 2.2k

All Works

Loading papers...

Rankless by CCL
2026